Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 197-204

  Cui, Jianxin ^a   Xi, Hongqing ^a   Cai, Aizhen ^a   Bian, Shibo ^a   Wei, Bo ^a   Chen, Lin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Gastric cancer; Prognosis; Sox7; Tumorigenesis; catenin

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; RNA; TRANSCRIPTION FACTOR SOX7; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; SOX7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GASTRIC CANCER CELL LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ADENOCARCINOMA; ADULT; AGED; BETA CATENIN; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SOXF TRANSCRIPTION FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; WNT SIGNALING PATHWAY;

EID: 84902684568     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1759     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Hartgrink HH, Jansen EP, van Grieken NC and van de Velde CJ: Gastric cancer. Lancet 374: 477-490, 2009.
3. Bowles J, Schepers G and Koopman P: Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227: 239-255, 2000.
4. Chew LJ and Gallo V: The Yin and Yang of Sox proteins: Activation and repression in development and disease. J Neurosci Res 87: 3277-3287, 2009.
5. Shiozawa M, Hiraoka Y, Komatsu N, Ogawa M, Sakai Y and Aiso S: Cloning and characterization of Xenopus laevis xSox7 cDNA. Biochim Biophys Acta 1309: 73-76, 1996. (Pubitemid 26382353)
6. Taniguchi K, Hiraoka Y, Ogawa M, Sakai Y, Kido S and Aiso S: Isolation and characterization of a mouse SRY-related cDNA, mSox7. Biochim Biophys Acta 1445: 225-231, 1999. (Pubitemid 29305296)
7. Stovall DB, Wan M, Miller LD, et al: The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol 183: 1645-1653, 2013.
8. Guo L, Zhong D, Lau S, et al: Sox7 is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 6: 1421-1430, 2008.
9. Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y and Byers SW: Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS One 3: e2714, 2008.
10. Gandillet A, Serrano AG, Pearson S, Lie ALM, Lacaud G and Kouskoff V: Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood 114: 4813-4822, 2009.
11. Kamachi Y and Kondoh H: Sox proteins: regulators of cell fate specification and differentiation. Development 140: 4129-4144, 2013.
12. Chan DW, Mak CS, Leung TH, Chan KK and Ngan HY: Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget 3: 1546-1556, 2012.
13. Katoh M: Expression of human SOX7 in normal tissues and tumors. Int J Mol Med 9: 363-368, 2002.
14. Hayano T, Garg M, Yin D, et al: SOX7 is down-regulated in lung cancer. J Exp Clin Cancer Res 32: 17, 2013.
15. Futaki S, Hayashi Y, Emoto T, Weber CN and Sekiguchi K: Sox7 plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating Gata-4 and Gata-6 expression. Mol Cell Biol 24: 10492-10503, 2004. (Pubitemid 39507885)
16. Zhang Y, Huang S, Dong W, et al: SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277: 29-37, 2009.
17. Zhong WD, Qin GQ, Dai QS, et al: SOXs in human prostate cancer: implication as progression and prognosis factors. BMC Cancer 12: 248, 2012.
18. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
19. Karim R, Tse G, Putti T, Scolyer R and Lee S: The significance of the Wnt pathway in the pathology of human cancers. Pathology 36: 120-128, 2004. (Pubitemid 38507872)
20. Polakis P: Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4: 2012.
21. Kolligs FT, Bommer G and Goke B: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66: 131-144, 2002. (Pubitemid 36091845)
22. Zhao P, Li Y and Lu Y: Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 10: 218, 2010.
23. Xi HQ and Zhao P: Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol 64: 498-503, 2011.
24. Filomena A, Saieva C, Lucchetti V, et al: Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results. Digestion 84: 70-77, 2011.
25. Wegner M: From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27: 1409-1420, 1999.
26. Kormish JD, Sinner D and Zorn AM: Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn 239: 56-68, 2010.
27. Willert K and Nusse R: Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8: 95-102, 1998. (Pubitemid 28122147)
28. Wu WK, Cho CH, Lee CW, et al: Dysregulation of cellular signaling in gastric cancer. Cancer Lett 295: 144-153, 2010.
29. Chan DW, Chan CY, Yam JW, Ching YP and Ng IO: Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/ degradation in liver cancer. Gastroenterology 131: 1218-1227, 2006. (Pubitemid 44515098)
30. Qi J and Zhu YQ: Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer. Curr Drug Targets 9: 548-557, 2008.
31. Takash W, Canizares J, Bonneaud N, et al: SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29: 4274-4283, 2001. (Pubitemid 33064768)
32. Li B, Ge Z, Song S, et al: Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients. Pathol Oncol Res 18: 1039-1045, 2012.
33. Castillo SD and Sanchez-Cespedes M: The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Ther Targets 16: 903-919, 2012.